List of Evzio drug patents

Evzio is owned by Kaleo Inc.

Evzio contains Naloxone Hydrochloride.

Evzio has a total of 32 drug patents out of which 0 drug patents have expired.

Evzio was authorised for market use on 03 April, 2014.

Evzio is available in solution;intramuscular, subcutaneous dosage forms.

Evzio can be used as use of an auto injector to administer naloxone hcl, use of a delivery device to deliver a bioequivalent dose of a naloxone composition via a needle, use of a delivery device to deliver a dose of naloxone, method for confirming dose delivery, use of a delivery device to administer a dose of naloxone.

The generics of Evzio are possible to be released after 20 March, 2035.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8313466 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(1 year, 9 months from now)

US8608698 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(1 year, 9 months from now)

US7918823 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(1 year, 9 months from now)

US9737669 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(1 year, 9 months from now)

US10737028 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(1 year, 9 months from now)

US10314977 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(1 year, 9 months from now)

US9056170 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(1 year, 9 months from now)

US8361029 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(1 year, 9 months from now)

US8425462 KALEO INC Devices, systems, and methods for medicament delivery
Nov, 2024

(1 year, 9 months from now)

US7731690 KALEO INC Devices, systems and methods for medicament delivery
Jan, 2025

(1 year, 11 months from now)

US8016788 KALEO INC Devices, systems and methods for medicament delivery
Mar, 2025

(2 years from now)

US10335549 KALEO INC Devices, systems and methods for medicament delivery
Apr, 2025

(2 years from now)

US9278182 KALEO INC Devices, systems and methods for medicament delivery
Feb, 2026

(3 years from now)

US8926594 KALEO INC Devices, systems and methods for medicament delivery
Mar, 2026

(3 years from now)

US7731686 KALEO INC Devices, systems and methods for medicament delivery
Jun, 2026

(3 years from now)

US10960155 KALEO INC Devices, systems and methods for medicament delivery
Jun, 2026

(3 years from now)

US9238108 KALEO INC Medicament delivery device having an electronic circuit system
Feb, 2027

(4 years from now)

US8206360 KALEO INC Devices, systems and methods for medicament delivery
Feb, 2027

(4 years from now)

US9724471 KALEO INC Devices, systems, and methods for medicament delivery
May, 2027

(4 years from now)

US7947017 KALEO INC Devices, systems and methods for medicament delivery
Mar, 2028

(5 years from now)

US7749194 KALEO INC Devices, systems, and methods for medicament delivery
Oct, 2028

(5 years from now)

US8231573 KALEO INC Medicament delivery device having an electronic circuit system
Nov, 2028

(5 years from now)

US8226610 KALEO INC Medical injector with compliance tracking and monitoring
Apr, 2029

(6 years from now)

US8021344 KALEO INC Medicament delivery device configured to produce an audible output
Nov, 2029

(6 years from now)

US9022022 KALEO INC Medicament delivery device for administration of opioid antagonists including formulations for naloxone
Feb, 2031

(8 years from now)

US10322239 KALEO INC Medicament delivery device for administration of opioid antagonists including formulations for naloxone
Feb, 2031

(8 years from now)

US8939943 KALEO INC Medicament delivery device for administration of opioid antagonists including formulations for naloxone
Feb, 2031

(8 years from now)

US9474869 KALEO INC Medicament delivery device for administration of opioid antagonists including formulations for naloxone
Feb, 2031

(8 years from now)

US10143972 KALEO INC Ultrafiltration membrane and a preparation method thereof
May, 2031

(8 years from now)

US8627816 KALEO INC Medicament delivery device for administration of opioid antagonists including formulations for naloxone
Feb, 2032

(9 years from now)

US9517307 KALEO INC Devices and methods for delivering opioid antagonists including formulations for naloxone
Jul, 2034

(11 years from now)

US10220158 KALEO INC Devices and methods for delivering opioid antagonists including formulations for naloxone
Mar, 2035

(12 years from now)

Drugs and Companies using NALOXONE HYDROCHLORIDE ingredient

Market Authorisation Date: 03 April, 2014

Treatment: Method for confirming dose delivery; Use of a delivery device to administer a dose of naloxone; Use of a delivery device to deliver a dose of naloxone; Use of an auto injector to administer naloxone hcl; Use of a delivery device to deliver a bioequivalent dose of a naloxone composition via a needle

Dosage: SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic